ARCHIVES

Guest Editorial: As Sequestration Becomes More Likely, Health Groups Must Make Themselves Heard

This article is from The Cancer Letter archive.

Vol. 39 No. 08 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001

Still Misperceptions On Hill About CRADA Between NCI, BMS

March 13, 1992

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

Volasertib and LDAC Doubled Response in Older Patients

July 25, 2014

FDA Publishes Parallel Track Rules, Accelerated Drug Approval Initiative

April 25, 1992

In Brief: Wittes DCT Acting Deputy Director; Spallone Leaves For Fox Chase; Ronald Evens Heads AUR

June 24, 1988